Sophi - Swiss Ophthalmology Innovation

Sophi - Swiss Ophthalmology Innovation is a Swiss company focused on designing and manufacturing advanced ophthalmic surgical systems, particularly for cataract surgery. Founded in 2014, Sophi developed the first wireless phacoemulsification system, enhancing flexibility and ease of use for surgeons in the operating room. The company emphasizes a holistic approach to device design, collaborating closely with medical professionals to optimize surgical workflows. The flagship product, the Sophi Phacoemulsification System, features wireless operation, ergonomic controls, and advanced fluid management capabilities. It allows up to 50 surgeons to save personalized settings and is designed for efficiency and safety during procedures. Sophi serves ophthalmic surgeons, surgical teams, and hospitals worldwide, supported by a network of local distributors and Centres of Excellence staffed by leading ophthalmologists. In January 2024, Sophi was acquired by Rayner, a UK leader in cataract surgery products. This acquisition enhances Rayner's portfolio with Sophi's innovative technology, furthering the commitment to delivering advanced surgical solutions globally.

• Employees 1
• Founded 2014